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PU.1/Spi-B Regulation of c-rel Is Essential
for Mature B Cell Survival
of genes. Ets family members are transcription factors
that mediate binding to a purine-rich GGAA/T core se-
quence and are characterized by a winged helix-loop-
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helix DNA binding domain (Gunther et al., 1990; Kodan-and M. Celeste Simon1,2,6
dapani et al., 1996; Macleod et al., 1992; Nye et al.,1 Abramson Family Cancer Research Institute
1992). Currently, there are more than 25 members of2 Howard Hughes Medical Institute
this family.University of Pennsylvania School of Medicine
PU.1, Spi-B, and Spi-C constitute an Ets subfamily,Philadelphia, Pennsylvania 19104
exhibiting structural similarity in several domains such3 Department of Pathology
as their DNA binding and PEST domains (Bemark et al.,4 Department of Medicine
1999). The 90% similarity in the DNA binding domain ofUniversity of Chicago
PU.1 and Spi-B make them indistinguishable in termsChicago, Illinois 60637
of DNA binding specificity (Rao et al., 1999b). PU.1 is5 The Walter and Eliza Hall Institute of Medical Research
expressed in most hematopoietic cells, including B lym-The Royal Melbourne Hospital
phocytes, monocytes, granulocytes, megakaryocytes,Parkville, Victoria 3050
mast cells, and immature erythroid cells (Hromas et al.,Australia
1993; Klemsz et al., 1990; Ray et al., 1992). We demon-
strated the essential role of PU.1 in hematopoiesis by
generating PU.1/ mice that die in utero and produceSummary
no lymphoid or myeloid cells (Scott et al., 1994). In con-
trast to PU.1, Spi-B expression is limited to lymphoidPU.1/Spi-B/ mice exhibit reduced numbers of im-
cells; high levels are detected in B cells, and low levelsmature and mature B lymphocytes, which exhibit se-
are found in T cells (Chen et al., 1995; Su et al., 1996).vere defects in response to BCR-mediated stimulation
Interestingly, expression of Spi-B in B lymphocytes isand poor survival. We found that expression of c-rel,
developmental stage dependent, with high levels in im-a member of the Rel/NF-B family, is dramatically re-
mature and mature B cells and low levels in pro-B andduced in PU.1/Spi-B/ splenic B cells. Analysis of
pre-B cells (Anderson et al., 1999; Su et al., 1996). Thisthe murine c-rel promoter identified three PU.1/Spi-B
expression pattern suggests that Spi-B plays a role inbinding sites critical for c-rel promoter activity. Further-
B cell function rather than B cell development. Indeed,more, reintroduction of Rel protein restored wild-type
Spi-B/ mice produce normal B cell numbers, butB cell numbers to mice reconstituted with PU.1/Spi-
Spi-B/ B cells proliferate poorly and die in response toB/ bone marrow. These findings are the first to dem-
BCR crosslinking in vitro (Su et al., 1997). Furthermore,onstrate that a member of the Rel/NF-B family is
immunized Spi-B/ mice form smaller splenic germinaldirectly regulated by Ets proteins and dissect the mo-
centers with increased numbers of apoptotic B cellslecular basis for the function of two Ets factors, PU.1
(Su et al., 1997). Given that Spi-B/ mice exhibit suchand Spi-B, in promoting B lymphocyte survival.
B cell defects, Spi-B must possess a unique function
not compensated by wild-type levels of PU.1 in lympho-Introduction
cytes. However, PU.1 likely masks certain phenotypes
in Spi-B/ mice, due to their identical DNA binding spec-Normal B cell development and response to antigenic
ificity. Analysis of the role of PU.1 in mature B cells is
stimulation depend on signaling through the B cell anti-
prevented by the complete lack of lymphocytes in
gen receptor (BCR) (Kurosaki, 1999). BCR-mediated sig-
PU.1/ mice. In an effort to study PU.1 function in
naling pathways have been defined in substantial detail. B lymphocytes, we crossed PU.1/ with Spi-B/ mice to
However, critical transcription factors and downstream generate PU.1/Spi-B/ mice. Of note, PU.1/Spi-B/
genes that regulate later stages of B cell differentiation, mice exhibit novel phenotypes with reduced numbers
proliferation in response to stimulation, isotype switch- of B220/IgM immature and IgM/IgD mature B cells
ing, and/or antibody secretion remain unclear. Neverthe- in bone marrow, spleen, and lymph nodes (Garrett-Sinha
less, two groups of transcription factors, Rel/NF-B and et al., 1999). In addition, these B cell functional defects
Ets proteins, have been implicated in this process are dramatically more severe than those of Spi-B/
(Glimcher and Singh, 1999). Rel/NF-B family members B lymphocytes in vivo and in vitro (Garrett-Sinha et al.,
(Rel, RelA, RelB, NF-B1, and NF-B2 in mammals) 1999). These data indicate that both PU.1 and Spi-B are
share a common N-terminal domain (Rel homology do- important for mature B cell function.
main) that is important for DNA binding, dimerization, PU.1 has been shown to regulate many genes that
and nuclear import (Baldwin, 1996). While Rel, RelA, and are important for B cell development and BCR-mediated
RelB contain C-terminal transactivation domains, NF-B1 signaling. These include Ig  heavy chain (Nelsen et al.,
and NF-B2 lack the transactivation activity. These indi- 1993), Ig J chain (Shin and Koshland, 1993), Ig light
vidual proteins interact with each other to form homo- chains ( and ) (Eisenbeis et al., 1993; Pongubala and
and heterodimers that control transcription of a variety Atchison, 1991; Pongubala et al., 1992), mb-1 (Ig) (Hag-
man and Grosschedl, 1992), B29 (Ig) (Omori and Wall,
1993), Btk (Himmelmann et al., 1996), LSP1 (Omori et6 Correspondence: celeste2@mail.med.upenn.edu
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al., 1997), and CD72 (Ying et al., 1998). Given that Spi-B
binds to PU.1 sites in all target genes examined thus
far, Spi-B presumably also regulates PU.1 target genes
in B cells. Therefore, mutation of Spi-B in combination
with reduced levels of PU.1 might decrease expression
of such B cell targets. However, the PU.1/Spi-B tar-
get genes listed above are expressed normally in
PU.1/Spi-B/ B cells (Garrett-Sinha et al., 1999), indi-
cating that one or more novel PU.1/Spi-B target gene(s)
may be downregulated in PU.1/Spi-B/ mice. Analysis
of downstream BCR signaling pathway effectors found
reduced phosphorylation of BLNK and PLC, but normal
syk activity, suggesting that a novel factor coupling
syk to downstream components is misexpressed in
PU.1/Spi-B/ B cells (Garrett-Sinha et al., 1999).
To identify novel PU.1/Spi-B target genes in B lympho-
cytes, we performed a subtractive hybridization using
RNA prepared from purified splenic PU.1/Spi-B/
and PU.1/Spi-B/ B cells (Rao et al., 1999a). We report
here that c-rel, a Rel/NF-B family member, is dramati-
cally downregulated in mutant B cells. Furthermore,
analysis of the murine c-rel promoter identified three
PU.1/Spi-B sites that are important for c-rel promoter
activity in B cells. Both PU.1 and Spi-B transactivate
the c-rel promoter. These results strongly suggest that
c-rel is a direct target of both PU.1 and Spi-B. Reintro-
duction of Rel protein restores wild-type B cell numbers
to mice reconstituted with PU.1/Spi-B/ bone mar-
row, indicating that misexpression of Rel is largely re-
sponsible for the B cell survival defect detected in
PU.1/Spi-B/ mice. Collectively, these findings estab-
Figure 1. Northern Blot Analysis of 3H12 in Splenic B Cells andlish that PU.1, Spi-B, and Rel are critical for regulating
Hematopoietic Cell Lines
immature and mature B cell survival.
(A) Northern blot analysis of 3H12 expression in purified splenic B cells
(more than 90% B220 based on flow cytometry) from PU.1/
Results Spi-B/, PU.1/Spi-B/, PU.1/Spi-B/, and PU.1/Spi-B/
mice. The same blot was then stripped and reprobed with an actin
probe for RNA loading control. The 3H12 expression level is shownClone 3H12 Is Underexpressed in PU.1/Spi-B/
as a percentage of wild-type cells after normalization for RNA load-Splenic B Cells and Encodes c-rel, a Member
ing. Similar results were obtained from multiple mice.of the Rel/NF-B Family
(B) Expression of 3H12 in murine hematopoietic cell lines using
To identify novel PU.1/Spi-B target gene(s) in B lym- Northern blot analysis of total RNA prepared from pro-B (NFS 70 c/
phocytes, we performed a PCR-based subtractive 10), pre-B (70 z/3 and 38 B9), immature B (WeHi 231), mature B
(A20), mature T (RMA), immature T (EL-4), macrophage (J774.1),hybridization using mRNA prepared from purified
erythroid (MEL), and fibroblast (3T3) cells. 28S rRNA is shown as awild-type and PU.1/Spi-B/ splenic B cells as de-
loading control.scribed previously (Rao et al., 1999a). Three PCR frag-
ments corresponding to genes underexpressed in
PU.1/Spi-B/ B cells were confirmed via Northern blot
correlating well with the expression of PU.1 and Spi-Banalysis of splenic B cell RNA from multiple mice (n 	
(see Discussion). To determine the identity of 3H12, a4 for each genotype). One gene, P2Y10, a mouse hetero-
320-bp cDNA obtained from our subtractive hybridiza-trimeric G protein-coupled heptahelical receptor, has
tion studies was used to probe a mouse splenocytebeen previously described (Rao et al., 1999a). Another
cDNA library, resulting in two overlapping clones (1.7clone, “3H12”, was also expressed at low levels in
and 2.1 kb). Combination of the data from these 1.7-kbPU.1/Spi-B/ splenic B cells. As shown in Figure 1A,
and 2.1-kb clones with cDNAs generated by 3
 and 5
3H12 was downregulated in splenic B cells obtained
RACE determined that 3H12 was identical to mousefrom both PU.1/Spi-B/ and PU.1/Spi-B/ mice at
c-rel. Thus, we determined that c-rel, like P2Y10, is down-approximately 50% of the levels of wild-type mice.
regulated in PU.1/Spi-B/ B cells.Moreover, the expression of 3H12 was further de-
creased (13% of wild-type) in PU.1/Spi-B/ B cells,
indicating that both PU.1 and Spi-B are important for The Murine c-rel Promoter Includes Multiple PU.1
and/or Spi-B Binding Sitesthe level of 3H12 mRNA. Northern blot analysis of total
RNA from multiple cell lines indicated that 3H12 is ex- Both PU.1 and Spi-B transcription factors are expressed
in immature and mature B lymphocytes (Rao et al.,pressed at high levels in B cells and at low levels in T cells
(Figure 1B). The expression of 3H12 in B cells appears 1999a). The low levels of Rel mRNA observed in
PU.1/Spi-B/ B cells imply that PU.1 and Spi-B controlto be highest in immature B lymphocytes, a pattern
PU.1 and Spi-B Regulate c-rel
547
Figure 2. The Murine c-rel Promoter Con-
tains at Least Three PU.1/Spi-B Binding Sites
(A) Sequences of five potential PU.1/Spi-B
binding sites in the murine c-rel promoter are
shown with GGAA core sequences boxed.
PU.1 and Spi-B consensus binding sites are
also shown.
(B) EMSAs of three PU.1/Spi-B binding sites
in the c-rel promoter using PU.1 or Spi-B IVT
proteins are shown.
(C) An EMSA of the 474 PU.1/Spi-B binding
site using nuclear extracts prepared from A20
mature B cells is shown. PI stands for preim-
mune serum.
c-rel expression directly or indirectly. Murine and human peted by wild-type P2Y10 oligonucleotides as described
in the Experimental Procedures (Figure 2B). PU.1 bind-c-rel promoters are very conserved and contain a puta-
tive PU.1 binding site at 548 (Grumont et al., 1993; ing may be stronger than that of Spi-B at sites 474
and 413. To further assess PU.1 and Spi-B bindingViswanathan et al., 1996). To determine if c-rel is likely
to be a direct target of PU.1 and/or Spi-B, a 1432-bp to the 474, 413, and 92 c-rel sites, EMSAs were
performed using nuclear extracts from A20 mature B cellsmurine c-rel promoter fragment was further investigated
for potential PU.1/Spi-B binding site(s). Out of 15 poten- known to express both PU.1 and Spi-B proteins (Figure
2C and data not shown). When the putative binding sitetial Ets GGAA or AGAA binding sites within the proximal
c-rel promoter region, 5 sites are consistent with a PU.1/ at 474 was incubated with A20 nuclear extract, two
complexes (A and B) were noted (lane 1). Complex A isSpi-B consensus site and adhere to the rule that C at
5, 4, 3 and T at 2, 1, and 1 is prohibited (Ray- specific for the PU.1/Spi-B binding site, since it was
outcompeted by wild-type but not mutated cold 474Gallet et al., 1995) (Figure 2A). To assess whether PU.1
and/or Spi-B bind these sites, electrophoretic mobility oligonucleotide (GGGAAG to TCCGGT) (lanes 2 and 3).
In direct contrast, the nonspecific nuclear complex Bshift assays (EMSAs) were performed using equal
amounts of in vitro-translated (IVT) PU.1 and Spi-B pro- was diminished by both wild-type and mutated cold
competitor. To determine if nuclear PU.1 and/or Spi-Bteins (see Experimental Procedures). Three sites at
474, 413, and 92 relative to the transcription start proteins are responsible for the formation of complex
A, a “supershift” experiment was performed using anti-site appeared to be binding sites for both IVT PU.1 and
Spi-B (Figure 2B). However, no DNA-protein complexes Spi-B or anti-PU.1 antibodies. The addition of preim-
mune serum (lane 4) and anti-Spi-B antibodies (lane 5)were observed when sites 548 and 404 were used
in EMSAs (data not shown). Binding at sites474,413, did not ablate complex A; however, incubation of nuclear
extract with anti-PU.1 antibody (lane 6) completely elimi-and92 is specific for PU.1/Spi-B recognition elements,
since DNA-protein complexes were specifically outcom- nated this complex. These results indicate that PU.1
Immunity
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protein was solely responsible for complex A in A20
nuclear extracts. The failure to detect a nuclear Spi-B-
DNA complex may result from lower levels of Spi-B
protein in A20 cells (Rao et al., 1999a) and/or lower
affinity of the474 site for Spi-B protein (see Figure 2B).
Similar results were observed when PU.1/Spi-B sites at
413 and 92 were used for EMSAs (data not shown).
PU.1/Spi-B Binding Sites Are Important for c-rel
Promoter Activity
To directly assess the functional importance of these
three PU.1/Spi-B binding sites for c-rel promoter activ-
ity, a 893-bp c-rel promoter fragment ( from634 to259)
was cloned into a promoterless human growth hormone
reporter gene, generating the pRelGH plasmid (Figure
3A). This fragment contains previously identified binding
sites for transcription factor Oct-1/2, NF-B, EGR-1, and
Sp-1 and exhibits high levels of promoter activity in
B cells (Grumont et al., 1993). Subsequently, all three
PU.1/Spi-B binding sites in pRelGH were mutated, re-
sulting in triple-mutated pRelGH (tmRelGH) (Figure 3A).
Mutation of these three binding sites reduced promoter
activity to 50% of the wild-type promoter in A20 B lym-
phocytes (Figure 3B). These results are significant given
that binding sites for Oct-1/2, NF-B, EGR-1, and Sp-1
remain intact. In contrast, no change in promoter activity
was observed between pRelGH and tmRelGH in ery-
throid cells MEL and 3T3 fibroblasts that express no
PU.1/Spi-B protein (Figure 3B and data not shown).
These data showed that PU.1 and/or Spi-B binding sites
are important for c-rel promoter activity in B cells. To
further analyze the role of PU.1 and Spi-B in c-rel tran-
scription, cotransfection experiments were performed
Figure 3. Three PU.1/Spi-B Binding Sites in the c-rel Promoter Are
(Figure 3C). Transfection of 3T3 cells with pRelGH and Important for c-rel Promoter Activity
wild-type PU.1 or Spi-B expression vectors increased
(A) A schematic diagram of the c-rel promoter reporter is shown
reporter activity 3- to 4-fold relative to empty vector with three PU.1/Spi-B binding sites indicated. In tmRelGH, three
(pcDNA3). However, transfection of mutant PU.1 or Spi-B PU.1/Spi-B binding sites were mutated. The arrow indicates the
transcription start site.lacking Ets DNA binding domains (PU.1Ets or Spi-BEts)
(B) A functional examination of PU.1/Spi-B binding sites for c-relor transcriptional activation domains (PU.1TA or Spi-
promoter activity using transient transfection of the wild-type c-relBTA) did not enhance c-rel promoter activity. We con-
promoter (pRelGH) or the promoter with PU.1/Spi-B sites mutatedclude that both PU.1 and Spi-B proteins can induce the
(tmRelGH) in several cell lines. The data represent results obtained
c-rel promoter. from four independent experiments.
(C) PU.1 and Spi-B transactivate the c-rel promoter reporter in 3T3
cells. PU.1 or Spi-B expression vectors (or mutants lacking transacti-Expression of Rel Protein Restores B Cell Numbers
vation or Ets DNA binding domains) were tranfected into 3T3 cellsin Mice Reconstituted with PU.1/Spi-B/
with the wild-type c-rel promoter reporter. The data represent meanBone Marrow
fold induction in comparison to the empty pcDNA3 vector from four
Functional analysis of murine Rel by gene-targeted independent experiments.
mutation has demonstrated a defect in c-rel/ B cell
proliferation and survival (Kontgen et al., 1995; Tumang
et al., 1998), similar to the phenotype observed in duced high titers of virus-expressing Rel protein, as
demonstrated by Western blot analysis of MIGR-Rel-PU.1/Spi-B/ mice (Garrett-Sinha et al., 1999). The dra-
matically reduced expression of Rel in PU.1/Spi-B/ infected 3T3 cells (data not shown).
To examine the in vivo consequences of Rel expres-B cells may be responsible for B cell survival defects
noted in PU.1/Spi-B/ mice. To determine if the rein- sion in PU.1/Spi-B/ B cells, we performed bone mar-
row engraftment of irradiated Rag-2/ mice. Bone marrowtroduction of Rel protein would overcome this deficiency
in PU.1/Spi-B/ B cells, we employed a retroviral- cells isolated from PU.1/Spi-B/ or PU.1/Spi-B/
mice were infected with control MIGR-GFP or MIGR-mediated approach to introduce c-rel into hematopoi-
etic cells derived from PU.1/Spi-B/ mice. A Rel cDNA Rel retroviruses and then injected into lethally irradiated
Rag-2/ mice. PU.1/Spi-B/ mice served as a control,was cloned into the MIGR-1 vector (Pui et al., 1999),
encoding a bicistronic mRNA including both Rel and since these mice exhibit normal B cell numbers (Su et
al., 1997) and have similar genetic background togreen fluorescent protein (GFP) (Figure 4A). Transfection
of BOSC 23-packaging cells with MIGR-Rel vector pro- PU.1/Spi-B/ mice. The source of the bone marrow
PU.1 and Spi-B Regulate c-rel
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Figure 4. Reintroduction of Rel Protein Re-
stores Bone Marrow B Cell Numbers in Mice
Reconstituted with PU.1/Spi-B/ Bone
Marrow Cells
(A) A diagram of the Rel retrovirus construct.
5
 LTR-mediated transcription generates a
bicistronic mRNA, with the GFP reading
frame accessed by an internal ribosomal en-
try site (IRES).
(B) Representative data from a single mouse
are shown. The source of bone marrow and
the type of retrovirus with which they were
infected specified four categories of reconsti-
tuted mice; PU.1/Spi-B//GFP-reconstitu-
ted mice are boxed. The percentages of GFP
(column I) and B220/IgM (column II) cells
from total bone marrow were determined by
immunostaining and flow cytometry. GFP
(column III) or GFP (column IV) populations
were then analyzed for numbers of B220/
IgM cells.
and the virus type classified the reconstituted mice into Rel protein has no apparent effect on immature B cells
that already express nearly normal levels of Rel proteinfour groups (n 	 3 for each group): PU.1/Spi-B//
GFP, PU.1/Spi-B//Rel, PU.1/Spi-B//GFP, and (see Discussion). To examine Rel function more closely,
B cell numbers in GFP and GFP bone marrow cellsPU.1/Spi-B//Rel. After 8 weeks, reconstituted mice
were sacrificed, and bone marrow, spleen, lymph nodes, were analyzed. All GFP cells in PU.1/Spi-B//Rel and
PU.1/Spi-B//Rel mice also express Rel. In theand thymus were harvested for FACS analysis of B and
T cells. Representative data are shown in Figures 4B PU.1/Spi-B//Rel mice, 12.1% of Rel-expressing cells
are B cells (Figure 4B, column III), compared with onlyand 5. These results were generated from a single mouse
of each experimental group. A total of 10%–35% of cells 4.4% in the Rel-negative cells (Figure 4B, column IV). Inter-
estingly, Rel expression in the control PU.1/Spi-B//Relfrom each tissue obtained expressed GFP, indicating
that these cells were derived from retrovirus-infected mice did not increase immature B cell numbers (3.2%
in GFP cells versus 5.2% in GFP cells). Thus, Relbone marrow precursors expressing retrovirus-encoded
genes (Figures 4B and 5, column I; data not shown). expression elevated the B cell numbers exclusively in
Rag-2/ mice reconstituted with bone marrow fromAnalysis of total bone marrow by B220/IgM immuno-
staining showed that control PU.1/Spi-B//GFP mice PU.1/Spi-B/ mice.
As observed in bone marrow, spleens fromcontain 4.7% B220/IgM immature B cells (Figure 4B,
column II). However, only 1.5% immature B cells were PU.1/Spi-B//GFP mice exhibit reduced numbers
of IgM/B220 B cells (25%) compared to controldetected in PU.1/Spi-B//GFP mice, representing a
60% reduction (Figure 4B, column II, boxed). This is con- PU.1/Spi-B//GFP mice (51%) (Figure 5, column II).
Importantly, this defect was once again corrected insistent with our previous data showing that B220/IgM
B cell numbers are reduced in PU.1/ Spi-B/ bone mar- PU.1/-Spi-B//Rel mice (52%). We conclude that Rel
protein expression is responsible for this phenotypicrow (Garrett-Sinha et al., 1999). We also observed a reduc-
tion of B220/IgM pro- and pre-B cells in reconstituted rescue, since more IgM/B220 B cells are present in
GFP cells (70%) (Figure 5, column III) than in GFPPU.1/Spi-B//GFP mice (2.2% in PU.1/Spi-B//GFP
and 11.4% in PU.1/Spi-B//GFP), as seen in the bone cells (51%) (Figure 5, column IV) in the splenocytes of
PU.1/Spi-B//Rel mice. A similar pattern was ob-marrow of many PU.1/Spi-B/ mice (Garrett-Sinha et
al., 1999). Importantly, reintroduction of Rel protein cor- served in IgM/IgD mature splenic B cells (Figure 5,
columns V–VII). As in the bone marrow and spleen, ex-rected B cell number defects in PU.1/Spi-B//Rel
mice (5.2% immature B cells and 11.9% pro- and pre- pression of Rel protein in reconstituted PU.1/Spi-B/
Rel mice also increased the B cell number in lymphB cells) (Figure 4B, column II). Of note, B cell numbers
in the control PU.1/Spi-B//Rel mice (4.3%) are not nodes (data not shown). However, reintroduction of Rel
protein had no effect on thymic T cell numbers in any ofsignificantly different from those of PU.1/Spi-B//
GFP mice (4.7%), indicating that forced-expression of the four classes of reconstituted mice (data not shown).
Immunity
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Figure 5. Reintroduction of Rel Protein Restores Splenic B Cell Numbers to Mice Reconstituted with PU.1/Spi-B/ Bone Marrow Cells
The arrangement of data is identical to that of Figure 4; besides the B220/IgM immature B cells, IgM/IgD mature B cells are also shown.
Moreover, no difference was observed in T cell numbers PU.1/Spi-B target genes underlying these functions re-
mained unclear. We now report that c-rel is directly regu-between GFP and GFP thymic cells. Therefore, Rel
protein appears to specifically promote B cell survival. lated by PU.1 and Spi-B in B cells. Importantly, expression
of Rel in mice reconstituted with PU.1/ Spi-B/ bone
marrow cells overcame the B cell survival defect, dem-Enforced Bcl-2 Expression Promotes Survival
of PU.1/Spi-B/ B Cells onstrating that misexpression of c-rel in PU.1/Spi- B/
B cells accounts for a major portion of this phenotype.To determine whether the reduced survival of
PU.1/Spi-B/ B cells was in part due to low levels of
Bcl-family members, we tested whether this defect c-rel Appears to Be a Direct Target Gene
of Both PU.1 and Spi-Bcould be overcome by enforced expression of a Bcl-2
transgene (Strasser et al., 1991). Wild-type and Rel/NF-B family members play important roles in B cell
development, differentiation, and survival (GerondakisPU.1/Spi-B/ mice were crossed to mice that carry a
Bcl-2 transgene under the control of the Ig heavy chain et al., 1999). Induction of Rel/NF-B proteins during pri-
mary B cell differentiation is developmental-stage de-enhancer (E) and SV40 promoter (see Experimental
Procedures). Results from representative mice gener- pendent, as RelA/p50 dimers are expressed predomi-
nantly in pro-B and pre-B cells, Rel/p50 in immature andated in these experiments are presented in Figure 6.
Enforced Bcl-2 expression increased the number of mature B cells, and RelB/p52 in plasmacytes (Grumont
and Gerondakis, 1994; Kistler et al., 1998; Liou et al.,B220/IgM and IgM/IgD B cells in PU.1/Spi-B/
bone marrow to numbers comparable to wild-type mice 1994; Miyamoto et al., 1994; Weih et al., 1994). However,
it is interesting that PU.1, Spi-B, and Rel levels increase(Figure 6). The Bcl-2 transgene also elevated B220/
IgM and IgM/IgD B cell numbers in PU.1/Spi-B/ concomitantly when primary pre-B cells undergo matu-
ration to immature IgM B cells (Anderson et al., 1999;spleens (Figure 6) and lymph nodes (data not shown).
However, unlike transduction of c-rel, the Bcl-2 trans- Grumont and Gerondakis, 1994; Kistler et al., 1998). The
murine c-rel promoter has previously been partiallygene increased B cell numbers in both control and mu-
tant animals (compare Figure 5 with Figure 6). These characterized (Grumont et al., 1993). A GC-rich 200-nt
region upstream of the major transcription start site wasresults suggest a nonspecific general effect of Bcl-2 on
survival (Strasser et al., 1991) and contrast with those shown to contain c-rel promoter activity in T cells. Sur-
prisingly, this promoter fragment is not sufficient forof c-rel. Bcl-2 can exert its effect independently of any
cofactors. In direct contrast, Rel must heterodimerize transcription in B cells (Grumont et al., 1993). In contrast,
elements located between nucleotides 640 and 202with other NF-kB family members, and its activity
is therefore dependent on other proteins (i.e., NF-B1, are critical for c-rel promoter activity in B cells (Grumont
et al., 1993). Interestingly, two newly identified PU.1/NF-B2, IB, etc.)
Spi-B binding sites (474 and 413) are within this
region. This region also contains two Rel/NF-B sitesDiscussion
(from 411 to 402 and from 260 to 251) and an Oct
site (from 438 to 431). Although these Rel/NF-B andOur previous analysis of PU.1/Spi-B/ mice showed
that expression of both PU.1 and Spi-B is critical for late- Oct sites are functionally important in promoter-driven
reporter assays (Grumont et al., 1993), the relative im-stage B cell survival and proliferative responses to BCR
stimulation (Garrett-Sinha et al., 1999). However, the portance of each of these transcription factors in con-
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Figure 6. Overexpression of Bcl-2 Gene Increased the B Cell Numbers in PU.1/Spi-B/ Bone Marrow and Spleen
PU.1/Spi-B//Bcl-2 mice were generated by crossing PU.1/Spi-B/ mice with Bcl-2 transgenic mice. Two- to three-month-old animals
were sacrificed, and single-cell suspensions were prepared from the bone marrow and spleen for flow cytometry analysis of IgM/B220 or
IgM/IgD B cells.
trolling Rel expression in B cells in vivo needs to be vivo B cell survival defect (Su et al., 1997). However, a
further decrease to 10%–13% clearly leads to the sur-determined. In contrast, PU.1 and Spi-B are critical for
Rel mRNA expression in IgM B cells, since Rel expres- vival phenotype noted in PU.1/Spi-B/ cells. Reintro-
duction of Rel protein into PU.1/Spi-B/ lymphocytession is dramatically reduced in PU.1/Spi-B/ B cells
in vivo (Figure 1A). In vitro transient transfection assays via the retroviral reconstitution system overcame this
B cell number defect. Moreover, there is a significant(Figures 3B and 3C) further emphasized the importance
of PU.1 and Spi-B in regulating c-rel. First, although the increase in immature and mature B cells in Rel-express-
ing cells in comparison to Rel-nonexpressing cells.mutated promoter still contained functional NF-B and
Oct sites, c-rel promoter activity was reduced 50% if These results demonstrated that misexpression of Rel
is the principle cause of B cell hypocellularity inthree PU.1/Spi-B binding sites were eliminated. Second,
PU.1 or Spi-B protein induced wild-type promoter activ- PU.1/Spi-B/ mice (Figures 4B and 5). This is consis-
tent with the notion that Rel is an antiapoptotic moleculeity 3- to 4-fold. Rel expression is sensitive to both PU.1
and Spi-B protein levels in B cells: Rel expression is in B cells. Rel has been demonstrated to regulate the
expression of two Bcl-2 family prosurvival genes, A1reduced (50%) in both PU.1/Spi-B/ and PU.1/
Spi-B/ B cells, indicating that wild-type levels of Spi-B and Bcl-xL (Chen et al., 2000; Grumont et al., 1999; Lee
et al., 1999; Zong et al., 1999). In particular, inductioncannot compensate for the loss of PU.1 and vise versa.
Consequently, a dramatic reduction was observed in of A1 is critical for B cell survival upon BCR stimulation
(Grumont et al., 1999). Misexpression of A1 and Bcl-xLPU.1/Spi-B/ B cells in vivo. Although PU.1 and Spi-B
exhibit highly conserved DNA binding regions, their in c-rel/ B cells may explain the increased apoptosis
upon BCR stimulation. Furthermore, expression oftransactivation domains are unique. Differential binding
affinities or cofactor interactions may explain why both Bcl-2 overcomes apoptosis in resting and activated
c-rel/ B cells (Grossmann et al., 2000). Of note, overex-proteins are required for Rel expression. We conclude
that both PU.1 and Spi-B regulate Rel expression during pression of Bcl-2 via a B cell-specific transgene in
PU.1/Spi-B/ mice also reversed the poor survival ofB lymphopoiesis.
mutant lymphocytes and elevated B cell numbers to
those detected in wild-type animals (Figure 6).Rel Expression Overcomes the B Cell Number
Defect in Mice Reconstituted with PU.1/Spi-B/ PU.1/Spi-B/ mice exhibit increased apoptosis in
splenic B cells (Garrett-Sinha et al., 1999). DecreasedBone Marrow
PU.1/Spi-B/ mice exhibit reduced numbers of imma- apoptosis upon Rel transduction may explain the rescue
of B cell numbers in PU.1/Spi-B//Rel-reconstitutedture (B220/IgM) and mature (IgM/IgD) B cells in
bone marrow and other lymphoid tissues such as the Rag-2/ mice. Importantly, apoptosis rates in Rel-
expressing B cells in PU.1/Spi-B//Rel-reconstitutedspleen, lymph nodes, and peripheral blood (Garrett-
Sinha et al., 1999). Interestingly, a 42% reduction in Rel mice were consistently reduced 2%–5% in comparison to
non-Rel-expressing B cells (data not shown). This reducedprotein in Spi-B/ mice (Figure 1A) fails to yield an in
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apoptosis is likely to become significant over a long fectors BLNK and PLC and poor proliferation (Garrett-
Sinha et al., 1999). We have recently shown that a differ-period of time (8 weeks after bone marrow engraftment).
It is interesting to note that GFP intensity in MIGR- ent PU.1/Spi-B target gene, the adaptor protein GrpL,
rescues both membrane proximal tyrosine phosphoryla-Rel-infected cells was much lower than that in control
MIGR-GFP cells (Figures 4B and 5, column I). This may tion and BLNK phosphorylation upon BCR stimulation
of mutant lymphocytes (L.A.G.-S. et al., unpublished data).reflect selection against cells that express high levels of
Rel protein. Another possibility is that Rel mRNA hinders However, overexpression of GrpL in PU.1/Spi-B/
B cells fails to overcome the survival defect. Therefore,ribosome access to the internal ribosome entry site
(IRES) to translate GFP. We note a reduction in pro- and distinct PU.1/Spi-B target genes likely account for differ-
ent B cell phenotypes noted in mutant mice. Analysispre-B cells in bone marrow of control PU.1/Spi-B/ /
Rel mice (8.9% among GFP cells and 3.8% in GFP of PU.1/Spi-B/ mice continues to be a useful ap-
proach to identify novel components of BCR-mediatedcells) (Figure 4B, column III and IV). Therefore, high levels
of Rel protein could be toxic for pro- and pre-B cells responses in lymphocytes.
that normally express very low levels of Rel (Liou et al.,
Experimental Procedures1994; Miyamoto et al., 1994; Weih et al., 1994). This
is consistent with high levels of Rel expression being
Splenic B Cell Purification and Northern Blot Analysisassociated with increased apoptosis in the developing B cells were purified from spleens of mice with the appropriate
avian embryo and bone marrow cultures (Abbadie et al., genotypes as described (Su et al., 1997). We purified B cells to more
1993). Thus, appropriate Rel protein levels are important than 90% homogeneity, as determined by flow cytometry using
B220 immunostaining. Total RNA isolation from primary B cells orfor B cell function; very high, as well as very low, levels
various cell lines and Northern blot analysis were performed usingof Rel may promote B cell death. Rel also plays an impor-
standard protocol.tant role in controlling B cell cycle progression, but the
molecular mechanisms by which c-rel/ B cells are
cDNA Amplification
blocked in the G1 phase remain obscure (Grumont et al., 3
 and 5
 RACE of 3H12 clones were performed using the Marathon
1998). Interestingly, in comparison with PU.1/ Spi-B/ / cDNA Amplification Kit (Clontech). A 1.0-kb 3
 RACE product was
GFP mice, B cell numbers in the GFP population were PCR amplified using a forward gene-specific primer (5
-AACCCAC
GCATGTCCTCATCATC-3
) and AP1. The 0.5–3.0-kb 5
 RACE prod-significantly increased in PU.1/Spi-B/ /Rel-reconsti-
ucts were generated using a reverse gene-specific primer (5
-AGtuted mice (Figure 4B, column IV and Figure 5, column
CACCAGTTAGGCCAGAGTGTACG-3
) and AP1. The specific PCRIV and VII), indicating that Rel may regulate other B cell
product was gel purified and cloned into TA vector PCR 2.1-TOPO
genes that promote B cell survival in a paracrine fashion. (Invitrogen). These clones were sequenced and blast searched
Another possibility is that some GFP cells actually ex- against GenBank.
press transduced Rel protein. Given the low levels of
GFP expression by cells transduced with the MIGR-Rel Electrophoretic Mobility Shift Assays (EMSA)
PU.1 and Spi-B IVT proteins were prepared using TNT Quick Cou-retrovirus, it is probably impossible to completely gate
pled Transcription/Translation System (Promega). The amount ofout infected cells.
S35-methionine-labeled PU.1 and Spi-B IVT proteins were measured
by SDS-PAGE and quantification using a Molecular Dynanic Phos-
Rel Misexpression May Not Fully Account phoImager, taking into consideration the number of methionines
for PU.1/Spi-B/ Phenotype in PU.1 and Spi-B. A20 nuclear extracts (NEs) were prepared as
previously described (Rao et al., 1999a). Mixing equal molar PU.1Although reintroduction of Rel protein overcame the
or Spi-B IVT proteins or 8 g A20 NE with 500,000 cpm double-B cell number defect in our bone marrow reconstitution
strand 32P-labeled oligonucleotide initiated the DNA-protein bindingassay, misexpression of Rel alone may not explain the
reaction. For competition experiments, cold competitor (200-fold
phenotype of reduced B cell numbers in PU.1/Spi-B/ molar excess) was added with radioactive oligonucleotide simulta-
mice. It is likely that Rel target genes also play a role in neously. For “supershifts”, preimmune or antiserum was preincu-
this phenomenon. Furthermore, mice lacking single Rel/ bated with NEs for 15 min on ice, followed by the addition of a
radioactive probe. DNA-protein complexes were resolved in a 6%NF-B transcription factors (including c-rel) exhibit no
polyacrylamide gel using 0.25 TBE. For EMSA, the following oligo-impairment of B cell development, but mutation in multi-
nucleotides were used: P2Y10 WT: 5
-CGAAAGAGGAAGTAGAGC-3
;ple Rel/NF-B family members leads to B cell defects.
P2Y10 MT: 5
-CGAAAGTCCGGTTAGAGC-3
; -474 WT: 5
-GCTC
NF-B1/NF-B2/ mice exhibit a block in B cell devel- TGGAGGGGAAGTGCGG-3
; -474 MT: 5
-GCTCTGGAGTCCGGTTG
opment at the immature B cell stage (Franzoso et al., CGG-3
; -412 WT: 5
-GCGAAATCGGGAAGAGGGG-3
; -412 MT:
1997; Iotsova et al., 1997). NF-B1/RelA/ mice exhibit 5
-GCGAAATCTCCGGTAGGGG-3
; 92 WT: 5
-CGGAGCCGGGAA
AGAAGAGG-3
; 92 MT: 5
-CGGAGCCTCCGGTGAAGAGG-3
. Thea block in B cell precursors (Horwitz et al., 1997). Of
underlined sequence corresponding to the PU.1/Spi-B core bindingnote, mice reconstituted with c-rel/RelA/ fetal liver
elements represents the difference between WT and mutant.cells exhibit reduced numbers of immature B cells (50%
of wild-type) and mature B cells (20% of wild-type)
Transient Transfections
(Grossmann et al., 1999), a pattern also observed in The c-rel promoter reporter construct, pRelGH, was constructed by
PU.1/Spi-B/ mice. Our preliminary data indicate inserting the c-rel promoter fragment into the XbaI-BamHI site of
the promoterless reporter pØGH (Nichols Institution), which containsnormal mRNA levels of RelA, NF-B1, and IB- in
a human growth hormone cDNA. The c-rel promoter fragment inPU.1/Spi-B/ splenic B cells. While RelA RNA levels
pRelGH was excised from HP-cat plasmid (Grumont et al., 1993)appear normal in mutant B cells, it seems possible that
(GenBank accession number X70690) using a Vent DNA polymerase-RelA function is abnormal in PU.1/Spi-B/ mice.
based PCR protocol (Hu and Gupta, 2000) via the following primer
PU.1/Spi-B/ mice not only exhibit reduced num- pairs: 5
-ACCTCTAGA(XbaI)CATTTATACAGAATGGGGTTA-3
,5
-AC
bers of B cells, but the surviving B cells display defective CGGATCC(BamHI)AAGGCAGCCAGTCAGTCAGTC-3
. The same
Vent-PCR protocol was used to mutate three PU.1/Spi-B bindingBCR-mediated phosphorylation of the downstream ef-
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sites in pRelGH by amplifying the full-length plasmid with mutations V (Caltag). The labeled cells were analyzed by FACS Calibur (Becton
Dickinson) using four color setting.(indicated by lowercase letters) incorporated into primers as shown:
-474A: 5
-ggaCTCCAGAGCACCCGGACAACTC-3
; -474B: 5
-ggtTG
CGGACAGCCAGCGCCC-3
; -413A: 5
-ggtAGGGGGAACCACCGGT Generation and Analysis of PU.1/Spi-B//Bcl-2 Animals
Transgenic mice (strain E-Bcl-2-22) expressing the human Bcl-2CGAAAAC-3
; -413B: 5
-ggaGATTTCGCACATGCAAATCTCCGC-3
;
92A: 5
-ggtGAAGAGGAGGCCCGGGGGTGGTCCGAG-3
; 93B: cDNA under the control of the SV40 promoter and the immuno-
globulin heavy chain enhancer were obtained from the Jackson5
-ggaGGCTCCTCTGGGTTTGCGGCTCACACC-3
.
Transfection of 3T3 cells with reporter and PU.1 or Spi-B expres- Laboratory (Strasser et al., 1991). These animals were crossed to
PU.1/Spi-B/ mice to generate PU.1/Spi-B//Bcl-2 animals.sion vectors (Rao et al., 1999b) was performed with SuperFect (Qia-
gen) according to the manufacture’s protocol. A total of 5  104 Two- to three-month-old animals were sacrificed, and single-cell
suspensions were prepared from the bone marrow and spleen. Forcells in 60-mm dishes were transfected with 1 g pRelGH, 1 g
reference plasmid MSV -galactosidase, and 3 g PU.1 or Spi-B ex- flow cytometry analysis, each sample was stained with FITC-labeled
anti-IgM monoclonal antibody and a PE-labeled monoclonal anti-pression plasmid. After 48 hr transfection, supernatants were collected
for human growth hormone assays (Nichols Institute) and cells were body (B220 or IgDa plus IgDb).
lysed for -galactosidase activity (Promega) to monitor transfection
efficiency. Human growth hormone activity was normalized to-galac- Acknowledgments
tosidase activity.
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